sefulness of zinc preparation administration in zinc deficiency dialysis patients
Not Applicable
- Conditions
- Zinc deficiency Latent zinc deficiency
- Registration Number
- JPRN-UMIN000042511
- Lead Sponsor
- Kawashima Hospital Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients receiving zinc preparations before the start of evaluation Patients who discontinued administration after exceeding the doctor's judgment and serum zinc concentration standard value Patients receiving more than the package insert of Polarezinc Orally Disintegrating Tablets
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method